Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 12—December 2008
Dispatch

Transmission of Atypical Bovine Prions to Mice Transgenic for Human Prion Protein

Vincent BéringueComments to Author , Laëtitia Herzog, Fabienne Reine, Annick Le Dur, Cristina Casalone, Jean-Luc Vilotte, and Hubert Laude
Author affiliations: Institut National de la Recherche Agronomique, Jouy-en-Josas, France (V. Béringue, L. Herzog, F. Reine, A. Le Dur, J.-L. Vilotte, H. Laude); Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Turin, Italy (C. Casalone)

Main Article

Table

Transmission of classical and atypical BSE isolates to transgenic mice expressing human prion protein (Met129)*

Isolate Origin
(identification no.) 1st passage
 2nd passage
 3rd passage
Total no. affected† Mean survival time‡ Total no. affected† Mean survival time‡ Total no. affected† Mean survival time‡
BSE France (3) 1/6§ 872 6/7 568 ± 65 8/8 523 ± 22
France (3) 2/6 627, 842
Germany¶ 1/4§ 802 6/6 677 ± 54 8/8 555 ± 24
Italy (128204) 0/5 606–775
Belgium 0/4 696–829
L-type Italy (1088) 9/9 607 ± 23 11/11 653 ± 13 NA
France (7) 7/7 574 ± 35 0/8# >450
France (10) 8/8 703 ± 19
France (11) 9/9 647 ± 26
H-type France (1) 0/6 376–721 0/7 350–850 NA
France (2) 0/6 313–626 0/8 302–755 NA
France (5) 0/10 355–838 NA

*BSE, bovine spongiform encephalopathy; NA, not available (experiments still ongoing).
†Mice with neurologic signs and positive for protease-resistant prion protein by Western blotting.
‡Days ± SE of the mean. For mice with negative results, only the range of survival time is given.
§First passage performed on hemizygous mice. Note that the primary transmission of France (3) isolate was performed on both hemizygous and homozygous mice.
¶One passage on transgenic mice expressing bovine prion protein (7).
#Ongoing experiment.

Main Article

References
  1. Wadsworth  JD, Collinge  J. Update on human prion disease. Biochim Biophys Acta. 2007;1772:598–609.
  2. Grassi  J, Creminon  C, Frobert  Y, Fretier  P, Turbica  I, Rezaei  H, Specific determination of the proteinase K-resistant form of the prion protein using two-site immunometric assays. Application to the post-mortem diagnosis of BSE. Arch Virol Suppl. 2000;16:197–205.PubMedGoogle Scholar
  3. Biacabe  AG, Laplanche  JL, Ryder  S, Baron  T. Distinct molecular phenotypes in bovine prion diseases. EMBO Rep. 2004;5:110–5. DOIPubMedGoogle Scholar
  4. Casalone  C, Zanusso  G, Acutis  P, Ferrari  S, Capucci  L, Tagliavini  F, Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A. 2004;101:3065–70. DOIPubMedGoogle Scholar
  5. Buschmann  A, Gretzschel  A, Biacabe  AG, Schiebel  K, Corona  C, Hoffmann  C, Atypical BSE in Germany—proof of transmissibility and biochemical characterization. Vet Microbiol. 2006;117:103–16. DOIPubMedGoogle Scholar
  6. Biacabe  AG, Morignat  E, Vulin  J, Calavas  D, Baron  TG. Atypical bovine spongiform encephalopathies, France, 2001–2007. Emerg Infect Dis. 2008;14:298–300. DOIPubMedGoogle Scholar
  7. Beringue  V, Andreoletti  O, Le Dur  A, Essalmani  R, Vilotte  JL, Lacroux  C, A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci. 2007;27:6965–71. DOIPubMedGoogle Scholar
  8. Capobianco  R, Casalone  C, Suardi  S, Mangieri  M, Miccolo  C, Limido  L, Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathog. 2007;3:e31. DOIPubMedGoogle Scholar
  9. Béringue  V, Bencsik  A, Le Dur  A, Reine  F, Lai  TL, Chenais  N, Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS Pathog. 2006;2:e112. DOIPubMedGoogle Scholar
  10. Baron  T, Bencsik  A, Biacabe  AG, Morignat  E, Bessen  RA. Phenotypic similarity of transmissible mink encephalopathy in cattle and L-type bovine spongiform encephalopathy in a mouse model. Emerg Infect Dis. 2007;13:1887–94.PubMedGoogle Scholar
  11. Baron  TG, Biacabe  AG, Bencsik  A, Langeveld  JP. Transmission of new bovine prion to mice. Emerg Infect Dis. 2006;12:1125–8.PubMedGoogle Scholar
  12. Kong  Q, Zheng  M, Casalone  C, Qing  L, Huang  S, Chakraborty  B, Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol. 2008;82:3697–701. DOIPubMedGoogle Scholar
  13. Béringue  V, Le Dur  A, Tixador  P, Reine  F, Lepourry  L, Perret-Liaudet  A, Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One. 2008;3:e1419. DOIPubMedGoogle Scholar
  14. Hecker  R, Taraboulos  A, Scott  M, Pan  KM, Yang  SL, Torchia  M, Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 1992;6:1213–28. DOIPubMedGoogle Scholar
  15. Béringue  V, Vilotte  JL, Laude  H. Prion agent diversity and species barrier. Vet Res. 2008;39:47. DOIPubMedGoogle Scholar

Main Article

Page created: July 22, 2010
Page updated: July 22, 2010
Page reviewed: July 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external